International Cancer Imaging Society Meeting and 18th Annual Teaching Course
Advancing Cancer Imaging:
Improving Patient Outcomes
Sun 07 Oct 2018 - Tue 09 Oct 2018
Palais de l’Europe, Menton, France
Meeting President: Prof. Wim Oyen, London, UK
Interactive Workshops
These one day teaching courses are limited to 20 participants, each with their own imaging workstation and content delivered through lectures and hands-on case based learning.
Courses in 2018
Masterclass in Imaging of Thoracic Neoplasms, London, Thu 17 May
»More Information » Register Now!
Masterclass in Imaging of Prostate Cancer, London, Fri 18 May
» More Information » Register Now!
Masterclass in Imaging of Gynaecological Cancer, London, Thu 01 Nov
» More Information Register Now!
Other Courses in 2018
Masterclass in Imaging of Oncological Whole Body MRI, London, Wed 07 Nov
If you would like to be kept updated about our courses please scroll down and register your interest in the turquoise box at the bottom of the homepage.
Join our Society
Do you believe that Cancer Imaging is important?
If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.
As a member you will also receive:
- Discounted registration fees for all our teaching courses
- Exclusive access to the members' area
- Exclusive access to posters and presentations from the annual teaching course
- 20% off the APC for submitting manuscripts to Cancer Imaging
About ICIS
The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.
We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.
Cancer Imaging Journal
Impact Factor 2.404
Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials. The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.
The whole course proved to cover a wide range of relevant topics to a very high standard. I would highly recommend it.
Register your interest for all ICIS courses
Please click on the link below to register your interest for future ICIS interactive courses. We will notify you in advance of registration opening, allowing you first refusal on our popular courses.
To register your interest, fill in the details below and click on the "Register Interest" button.
Join our mailing list
If you want to be kept up to date on what's happening with ICIS, click on the "Subscribe" button below.
Cancer / Oncology News From Medical News Today
'Biomedical tattoo' might catch cancer early
Published: Sun, 22 Apr 2018 00:00:00 PDT
Medical research is reaching a new frontier with implants that can accurately spot early signs of cancer. Yet the road from laboratory to patient is long.
Is it lung cancer? This blood test can tell
Published: Thu, 19 Apr 2018 08:00:00 PDT
To tell lung cancer from benign tumors, specialists often have to use invasive methods. Yet researchers say that a simple blood test can change that.
Added to chemotherapy, this drug doubles lung cancer survival
Published: Thu, 19 Apr 2018 07:00:00 PDT
Adding immunotherapy to chemotherapy doubled survival in a trial of metastatic nonsquamous non-small cell lung cancer lacking EGFR and ALK mutations.
Prostate cancer: Big data unlocks 80 new drug targets
Published: Tue, 17 Apr 2018 08:00:00 PDT
In the largest study of its type, researchers find several new prostate cancer drug targets by harvesting and analyzing reams of genetic data.
Two common iron supplements may cause cancer
Published: Mon, 16 Apr 2018 09:00:00 PDT
Researchers find that certain iron supplements — called ferric citrate and ferric EDTA — increase the levels of a cancer biomarker.
Breast cancer: Common drugs may halt post-surgery relapse
Published: Sun, 15 Apr 2018 00:00:00 PDT
Some people develop early metastases following breast cancer surgery. New research sheds light on why that happens, and how it might be prevented.
Personalized vaccine fights off cancer in clinical trial
Published: Fri, 13 Apr 2018 09:00:00 PDT
A groundbreaking new pilot study designs personalized tumor vaccines for people with late-stage ovarian cancer. The results are promising.
Cancer: New drug may fight treatment resistance
Published: Thu, 12 Apr 2018 07:00:00 PDT
A new drug that blocks a molecule that cancer cells rely on for transcribing genetic information shows promise in tackling treatment-resistant tumors.
How blood flow helps cancer to spread
Published: Wed, 11 Apr 2018 08:00:00 PDT
A study shows that blood flow plays a key role in helping migrating cancer cells to exit the bloodstream and seed secondary tumors elsewhere in the body.
How can we stop fat cells from fueling cancer?
Published: Tue, 10 Apr 2018 08:00:00 PDT
Understanding just how cancer uses our body's metabolism against us is challenging. A new study describes how tumors use fat cells to power their growth.
Why do my gums look white?
Published: Tue, 10 Apr 2018 06:00:00 PDT
White spots on the gums have many causes. These include mild conditions such as mouth ulcers but could also be a sign of more severe conditions, which could potentially include cancer. White spots on the gums may cause pain or other symptoms Treatment depends on the cause. Learn more about white spots on the gums here.
Could berries help to fight cancer?
Published: Fri, 06 Apr 2018 09:00:00 PDT
According to new research, there's more to the berry than its delicious taste. Its pigments may offer new ways to stop cancer and slow the aging process.
Why does cancer arise? Landmark study provides unique insight
Published: Fri, 06 Apr 2018 07:00:00 PDT
A huge study published in a slew of papers has analyzed over 11,000 tumors from 33 cancers and reclassified them by their genomic and molecular makeup.
Dual attack with two existing drugs destroys lung cancer
Published: Wed, 04 Apr 2018 08:00:00 PDT
Lung cancer is the leading cause of cancer death in the U.S. A new study finds a two-pronged approach that could significantly improve survival rates.
'Natural insecticide' kills advanced prostate cancer cells
Published: Wed, 04 Apr 2018 07:00:00 PDT
Scientists identify a class of drugs that selectively targets and kills advanced prostate cancer cells that lack the tumor-suppressor protein PTEN.
Newly created compound boosts anti-cancer immunity
Published: Wed, 04 Apr 2018 00:00:00 PDT
The results of a study that took years to conduct are finally in: scientists have devised a compound that can boost our immunity against cancer.
New colon cancer drugs may arise from protein discovery
Published: Tue, 03 Apr 2018 08:00:00 PDT
Researchers have uncovered new mechanisms by which a protein called APC can prevent colon cancer, a discovery that could lead to new drug treatments.
New drug attacks cancer-causing genes
Published: Sat, 31 Mar 2018 00:00:00 PDT
A new drug that targets cancer-causing genes may help to improve cancer survival rates. Researchers also hope that it might halt obesity-related cancers.
How lung cancer cells disguise themselves to evade chemo
Published: Thu, 29 Mar 2018 00:00:00 PDT
New research finds that a genetic mutation makes lung cancer cells morph into gastrointestinal cells. The mechanism may explain drug-resistant lung cancer.
Newly found organ may lead to 'dramatic medical advances'
Published: Wed, 28 Mar 2018 00:00:00 PDT
The discovery has a variety of implications, ranging from a better understanding of cancer metastasis to that of wrinkles and the skin aging process.
